{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:42:44Z","timestamp":1783568564740,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtcvs.2023.08.024","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:15:03Z","timestamp":1692670503000},"page":"1929-1935.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non\u2013small cell lung cancer: Evidence for surgery in advanced disease"],"prefix":"10.1016","volume":"167","author":[{"given":"Nathaniel","family":"Deboever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza J.","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Sepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara A.","family":"Vaporciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumil J.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara B.","family":"Antonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2023.08.024_bib1","doi-asserted-by":"crossref","first-page":"e341S","DOI":"10.1378\/chest.12-2361","article-title":"Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Socinski","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijrobp.2018.08.050","article-title":"Local consolidative therapy (LCT) improves overall survival (OS) compared to maintenance therapy\/observation in oligometastatic non-small cell lung cancer (NSCLC): final results of a multicenter, randomized, controlled phase 2 trial","volume":"102","author":"Gomez","year":"2018","journal-title":"Int J Radiat Oncol Biol Physiol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib3","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jtcvs.2020.02.134","article-title":"Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer","volume":"161","author":"Mitchell","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cllc.2019.07.007","article-title":"Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non\u2013small-cell lung cancer","volume":"21","author":"Mitchell","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jso.23701","article-title":"Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases","volume":"110","author":"Yang","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jvir.2014.12.006","article-title":"Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients","volume":"26","author":"Moore","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib11","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib12","article-title":"Surgical complexity of pulmonary resections performed for oligometastatic NSCLC","volume":"3","author":"Antonoff","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.athoracsur.2022.03.044","article-title":"Kaplan-Meier survival, actuarial survival, censoring, and competing events-what is what?","volume":"114","author":"Hage","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib14","series-title":"The MD Anderson Manual of Medical Oncology, 4e","article-title":"Non\u2013small cell lung cancer: general principles, management of localized disease, and treatment of metastatic disease without oncogene drivers","author":"Altan","year":"2022"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jso.27165","article-title":"The \u201cnew\u201d oligometastatic disease state and associated therapies\u00a0in non-small cell lung cancer: a narrative review","volume":"127","author":"Na","year":"2023","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12885-016-2379-x","article-title":"Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer","volume":"16","author":"Fleckenstein","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2006.09.006","article-title":"Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)","volume":"81","author":"Khan","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J Natl Cancer Institute"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib19","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET Phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib20","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib21","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non\u2013small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non\u2013small-cell lung cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41591-020-01224-2","article-title":"Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial","volume":"27","author":"Cascone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib25","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in resected EGFR-mutated non\u2013small-cell lung cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib27","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3390\/cancers14102524","article-title":"The role of surgery for oligometastatic non-small cell lung cancer","volume":"14","author":"Euhus","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib28","unstructured":"MD Anderson Cancer Center. Randomized phase III trial of local consolidation therapy (LCT) after nivolumab and ipilimumab for immunotherapy-naive patients with metastatic non-small cell lung cancer (LONESTAR). NCT03391869. Accessed January 17, 2023. https:\/\/www.clinicaltrials.gov\/study\/NCT03391869"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib29","unstructured":"MD Anderson Cancer Center. Osimertinib, surgery, and radiation therapy in treating patients with stage IIIB or IV non-small cell lung cancer with EGFR mutations, NORTHSTAR study. NCT03410043. Accessed January 17, 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03410043."},{"key":"10.1016\/j.jtcvs.2023.08.024_bib30","unstructured":"MD Anderson Cancer Center. Local consolidative therapy and brigatinib in treating patients with stage IV or recurrent non-small cell lung cancer. NCT03707938. Accessed January 17, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03707938"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib31","unstructured":"University College of London. Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (SARON). NCT02417662. Accessed January 17, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02417662"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib32","unstructured":"University of Wisconsin, Madison. Phase Ib study of stereotactic body radiotherapy (SBRT) in oligometastatic non-small lung cancer (NSCLC) with dual immune checkpoint inhibition. NCT03275597. Accessed January 17, 2023. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03275597"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/SLA.0b013e31826b4be6","article-title":"Hospital procedure volume should not be used as a measure of surgical quality","volume":"256","author":"LaPar","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib34","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SLA.0b013e31821d4bdd","article-title":"The relationship between hospital lung cancer resection volume and patient mortality risk","volume":"254","author":"Kozower","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jtcvs.2020.06.138","article-title":"Regionalization in thoracic surgery: the importance of the team","volume":"161","author":"Darling","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jtcvs.2014.01.030","article-title":"The\u00a0impact of hospital and surgeon volume on the 30-day mortality of lung cancer surgery: a nation-based reappraisal","volume":"148","author":"Falcoz","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2023.08.024_bib37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/ejcts\/ezz095","article-title":"Do individual surgeon volumes affect outcomes in thoracic surgery?","volume":"56","author":"Harrison","year":"2019","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323007353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522323007353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:39:57Z","timestamp":1780277997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522323007353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022522323007353"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.08.024","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non\u2013small cell lung cancer: Evidence for surgery in advanced disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2023.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}